Top 10 Health Care VC Funds & Investors in Latvia (August 2026)
For AI agents: Short investor table (Markdown), Detailed investor list (Markdown)
| Investor | Relevant Deals | Geography | Stage | Focus | Round Size |
|---|---|---|---|---|---|
|
FlyCap
VC Fund
|
3 | Latvia, Estonia, The Netherlands | Seed, Debt Financing | Health Care, Rental, Medical | $55k–$2.9M |
|
Imprimatur Capital Fund Management
VC Fund
|
3 | Latvia, United States, United Kingdom | Seed, Debt Financing | Software, Information Technology, Apps | $63k–$549k |
|
SOSV
VC Fund
|
2 | United States, India, United Kingdom | Seed, Convertible Note, Pre-Seed | Biotechnology, Health Care, Software | |
|
ZGI Capital
VC Fund
|
2 | Latvia, Estonia, United Kingdom | Seed, Debt Financing | Manufacturing, Consulting, Construction | $55k–$981k |
|
Abingworth
VC Fund
|
2 | United States, United Kingdom, France | Series B, Series A, Series C | Biotechnology, Health Care, Pharmaceutical | $14M–$120M |
|
Qiming Venture Partners USA
VC Fund
|
2 | United States, Canada, China | Series A, Series B, Seed | Biotechnology, Health Care, Pharmaceutical | $6M–$116M |
|
Alexandria Venture Investments
VC Fund
|
1 | United States, Canada, France | Series A, Series B, Seed | Biotechnology, Health Care, Therapeutics | $2M–$150M |
|
Surveyor Capital
VC Fund
|
1 | United States, China, Canada | Series B, Post-IPO Equity, Series C | Biotechnology, Health Care, Therapeutics | $41M–$280M |
|
Roche Venture Fund
VC Fund
|
1 | United States, United Kingdom, Spain | Series B, Series A, Series C | Biotechnology, Health Care, Therapeutics | $5M–$125M |
|
Citadel
VC Fund
|
1 | United States, India, Latvia | Series C, Private Equity, Seed | Information Technology, Biotechnology, Health Care | $11M–$2B |
| Access all 56 VC funds in Latvia Health Care startups. | |||||
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Investor list
FlyCap AIF is a Venture Capital Fund of total size of 15.75 MEUR. The Fund provides growth capital for Latvia based SME’s in a form of investments in equity and mezzanine capital.
Show more...Investment focus
- Industry: Health Care, Rental, Medical
- Stage:Seed, Debt Financing
- Geography: Latvia, Estonia, The Netherlands
Investor stats
- Total investments: 30
- Round size: Seed $55k–$2.9M; Debt Financing $329k–$2.2M
- Lead/follow: 40% lead, 60% follow
- Last fund: May invest from a new fund soon — raised $18M in 2013
Portfolio highlights
- Mintos — Mintos is a platform that provides retail investors with an accessible way to build wealth through loan-based investments. Through their platform retail investors can invest in a diversified way in income-producing assets to build wealth in the long term. They implement environmental, social, and employee matters, respect for human rights,anti‐corruption, and anti‐bribery matters within their remuneration policy practices and other internal company documents.
- Tapcore — Tapcore is the only solution on the market that enables mobile developers to monetize pirated copies of their apps through advertising. Established in 2015, we are a remote company with headquarters in the Netherlands. Currently we serve over 150 million ad requests daily (and counting!).
- Elmo — In our mobility-focused operations, we wanted to optimize business and decrease environmental impact, so we created remote control technology to deliver cars.
Imprimatur Capital Fund Management is a venture capital firm focusing on high-technology at an early stage in its commercial development. We invest in start-up technology businesses which are based on innovative intellectual property, are led by strong teams and have high international growth potential.Imprimatur Capital Fund Management, based inLatvia, manages seed and start-up funds with investors including the Latvian Guarantee Agency, other institutional investors and some private investors. The company source investment opportunities primarily from the Baltic/Nordic/Russia region.Imprimatur Capital Fund Management is a partner firm of Imprimatur Capital Ltd, headquartered in London and with investment operations in Europe, Russia, Asia Pacific, Latin America and the US.
Show more...Investment focus
- Industry: Software, Information Technology, Apps
- Stage:Seed, Debt Financing
- Geography: Latvia, United States, United Kingdom
Investor stats
- Total investments: 81
- Round size: Seed $131k–$549k; Debt Financing $63k–$70k
- Lead/follow: 20% lead, 80% follow
- Last fund: May invest from a new fund soon — last raise in 2010
Portfolio highlights
- Axial3D — Leading the way with the latest 3D imaging, models, and devices
- afriQloud — AfriQloud provides a white-labeled cloud computing solution to telecom operators, internet service providers, system integrators, and managed information technology service providers.
- Sonarworks — SoundID Reference software calibrates your speakers and studio headphones, so you can trust that every mix will translate.
SOSV is a global, deep tech venture capital firm that operates the HAX and IndieBio startup development programs focused on human and planetary health. SOSV invests $500,000 in startups at their inception as they onboard either HAX or IndieBio for a 4-6 month period designed to accelerate the raise of their next institutional round. SOSV joins thelater rounds of HAX and IndieBio graduates. HAX, based in a 35,000 sq ft facility in Newark, NJ, is equipped with machine tools, 3D printers, chemical, electrical and mechanical engineering labs, as well as on-staff engineering and design experts. SOSV's IndieBio has locations in NYC and San Francisco, both of which offer extensive services and facilities to founders including on-site BSL-2 labs, well equipped lab benches and hoods, and advanced lab equipment, such as chromatography equipment.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Software
- Stage:Seed, Convertible Note, Pre-Seed
- Geography: United States, India, United Kingdom
Investor stats
- Total investments: 1482
- Lead/follow: no public data
Portfolio highlights
- MixRift — MIXRIFT - game developers specialized in Mixed Reality
- unspun — From 3D scan to perfect fitting custom jeans. unspun makes each pair of jeans unique to your actual body and design. On a mission to reduce global carbon emissions by 1%. As seen in Fast Company's World Changing Ideas, Time's Best Inventions, and PopSci's Best of What's New. Welcome to the future of apparel.
- Mesa Quantum — Unlock the potential of chip-scale quantum sensing for enhanced Position, Navigation, And Timing capabilities. Explore Mesa Quantum's practical solutions.
ZGI Capital is the fund management company that manages "ZGI fund”, that was founded to support entrepreneurs lacking start-up capital for their business. The total amount of assets available for venture capital investments is of EUR 7.4M. Combined with bank financing, this will allow to finance investment projects with total assets of up toEUR 30M. The fund acts on behalf of various investors including the State.
Show more...Investment focus
- Industry: Manufacturing, Consulting, Construction
- Stage:Seed, Debt Financing
- Geography: Latvia, Estonia, United Kingdom
Investor stats
- Total investments: 28
- Round size: Seed $55k–$896k; Debt Financing $110k–$981k
- Lead/follow: 89% lead, 11% follow
- Last fund: May invest from a new fund soon — last raise in 2017
Portfolio highlights
- Echoo Group — Echoo Group provides Smart Home, Building automation system (BMS), Engineering network solutions from design to solution.
- RoyaltyRange — RoyaltyRange is a data provider with 4 professional databases covering Royalty rates, Service fees, Loan rates, Companies' financials.
- Electrify — Electrify manufactures electric buses and minibusses offers charging solutions, and bus infrastructure maintenance.
We are Abingworth, a trans-atlantic bio-science investment firm with a deep understanding of both the science and markets we invest in.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Pharmaceutical
- Stage:Series B, Series A, Series C
- Geography: United States, United Kingdom, France
Investor stats
- Total investments: 173
- Round size: Series A $14M–$115M; Series B $18M–$95M; Series C $20M–$120M
- Lead/follow: 31% lead, 69% follow
- Last fund: Likely still investing — raised $356M in 2023
Portfolio highlights
- Attenua — 100% satisfaction guaranteed. Hassle-free shopping. We help you find the right domain name.
- Iambic — Iambic has created a cutting-edge AI-driven platform to tackle the most challenging design problems in drug discovery and address unmet patient need.
- Atsena Therapeutics — Atsena is a clinical-stage gene therapy company, focused on bringing the life-changing power of genetic medicine to reverse or prevent blindness.
Qiming Venture Partners USA, founded in 2017, is a healthcare venture capital firm and healthcare investor with deep technical expertise that allows them to identify tomorrow's innovations early and strong operational experience with a hands-on approach that makes us the investor of choice for early-stage biotech companies.Because of theirproven, hands-on approach to supporting CEOs and scaling operations, its partners are frequently sought after to serve on company boards. They are respected business and thought leaders.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Pharmaceutical
- Stage:Series A, Series B, Seed
- Geography: United States, Canada, China
Investor stats
- Total investments: 40
- Round size: Seed $6M–$55M; Series A $14M–$92M; Series B $36M–$116M
- Lead/follow: 20% lead, 80% follow
- Last fund: Likely still investing — fund raised in 2022
Portfolio highlights
- Dualitas Therapeutics — Dualitas Therapeutics is a biotechnology company pioneering best-in-class, next-generation bispecific antibodies for immune and inflammatory diseases and beyond.
- Tenpoint Therapeutics — Tenpoint Therapeutics Ltd. is a global, clinical-stage biotech company developing groundbreaking treatments to rejuvenate vision in the aging eye.
- Rhino Federated Computing — Rhino Federated Computing solves one of the biggest challenges in AI: seamlessly connecting siloed data through federated computing.
Alexandria Venture Investments is a venture capital firm that develops work in real estate technology, and healthcare sectors. The company's strategic venture capital platform is Alexandria Venture Investments. Since its inception in 1996, the company has invested in disruptive life science, agrifood tech, and technology companies that aredeveloping transformative new modalities and platforms to meaningfully improve human health.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Therapeutics
- Stage:Series A, Series B, Seed
- Geography: United States, Canada, France
Investor stats
- Total investments: 270
- Round size: Seed $2M–$31M; Series A $12M–$100M; Series B $25M–$150M
- Lead/follow: 7% lead, 93% follow
Portfolio highlights
- Triveni Bio — Triveni Bio is at the forefront of human genetics, cutting-edge antibody design, and precision medicine, pioneering the identification of new disease targets.
- Vedana Therapeutics — Vedana Therapeutics is a Seattle biotechnology company developing next-generation antibody therapies for migraine prevention.
- CREATE Medicines — Myeloid Therapeutics is an immunology company focused on combining immunologic insights with cutting-edge technologies to harness myeloid cells to eradicate cancer and other diseases. The Company's ATAKTM platform technology can be broadly applied, and it is initially advancing a cell therapy program for T cell lymphoma and a primed monocyteapproach to treat glioblastoma. The ATAK platform is scalable to multiple treatment modalities and other disease areas in collaboration with partners.
Surveyor Capital is a fundamental equities business. Surveyor’s sector-aligned investment teams aim to generate alpha through a deep understanding of each company’s strategy, management teams, drivers of performance, and cyclical and secular industry trends over the medium and long term.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Therapeutics
- Stage:Series B, Post-IPO Equity, Series C
- Geography: United States, China, Canada
Investor stats
- Total investments: 170
- Round size: Series B $60M–$170M; Series C $60M–$226M; Post-IPO Equity $41M–$280M
- Lead/follow: 9% lead, 91% follow
Portfolio highlights
- ADCendo — ADCendo ApS is a biotech company dedicated to developing new types of anti-cancer drugs. We focus on antibody-drug conjugates (ADCs) directed at novel targets, that have been found to be overexpressed by several cancer forms, that are all characterized by a significant unmet need for novel treatment.
- Sol-Gel Technologies — Sol-Gel designs and delivers innovative dermatological drugs ranging from completely non-leachable to highly-controlled-release of unique formulations and compounds.
- Perspective Therapeutics — Perspective Therapeutics is dedicated to finding the best ways to deliver remedies to patients and their medical needs, and they believe in a targeted, individualized approach to cancer treatment. We design treatments that are given exactly where the doctor needs them.
We are the corporate venture fund of Roche, a global leader in bringing medicines and in vitro diagnostics to the benefit of patients.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Therapeutics
- Stage:Series B, Series A, Series C
- Geography: United States, United Kingdom, Spain
Investor stats
- Total investments: 120
- Round size: Series A $7.5M–$86M; Series B $10M–$125M; Series C $5M–$105M
- Lead/follow: 12% lead, 88% follow
Portfolio highlights
- AveXis — Discover how Novartis Pharmaceuticals brings innovative medicines to market to enhance health outcomes for patients and offer solutions to healthcare providers.
- Mironid — Google Analytics is a web analysis service provided by Google. Google utilizes the data collected to track and examine the use of www.mironid.com, to prepare reports on its activities and share them with other Google services. Google may use the data collected to contextualize and personalize the ads of its own advertising network.
- Cour Pharmaceuticals Development — Reprogramming the immune system. Restoring lives.At COUR, we are developing targeted therapies that re-establish calm within the immune system and help rest ...
We are an alternative investment manager working on behalf of the world's preeminent institutions. Discover our work, teams, careers and more.
Show more...Investment focus
- Industry: Information Technology, Biotechnology, Health Care
- Stage:Series C, Private Equity, Seed
- Geography: United States, India, Latvia
Investor stats
- Total investments: 19
- Round size: Series C $75M–$2B; Private Equity $11M–$120M
- Lead/follow: 16% lead, 84% follow
Portfolio highlights
- Nscale — Nscale is an AI GPU cloud platform that provides scale computing to the generative AI market. It develops AI-ready data centers, deploys GPU infrastructure, and delivers AI cloud services. Its AI private cloud platform supports the entire generative AI lifecycle, enabling developers to run and train AI models. It also provides bare metal andvirtualized GPU nodes, Kubernetes-native services (NKS), AI workload scheduling empowered by SLURM, and advanced serverless and dedicated inferencing options.
- Ionic Digital — Ionic Digital is an innovator in the bitcoin mining industry.
- Texas Stock Exchange — The Texas Stock Exchange will focus on enabling U.S. and global companies to access U.S. equity capital markets and will provide a venue to trade and list public companies and the growing universe of exchange-traded products. TXSE will be a fully electronic, national securities exchange that will seek registration with the U.S. Securities and Exchange Commission.
Health Care VC funding in Latvia at a glance
Stats across 42 deals from 56 investors.
Access all 56 VC funds in Latvia Health Care startups.
Open ListFAQ
Is Shizune data fresh/accurate?
Shizune has monitored hundreds of funding sources since 2020.
Our investor database is updated every day, so investor data is always fresh.
All metrics are calculated from confirmed public rounds, so the data is accurate.
Can I download investor list?
To download the Health Care VC Funds in Latvia investor list, create a Shizune account. This investor list will be added to your saved investors and available for download in the export section.
You can also enrich the investor list with investor emails, phones, LinkedIns, and other contact data.
Can I access investor database?
To access all 56 VC funds investing in Latvia Health Care startups and 48,091+ more investors, create a Shizune account.
Shizune has a database of 48,091 investors. Our investor database is fresh and updated daily.
The Shizune investor database has information on investor investment focus, investor contact data, and full investor portfolio since 2020.
You can enrich with email and download the data.
Does Shizune have investor emails and contacts?
Shizune enriches investors with contact data that includes: email, phones, LinkedIn, socials, website, and others.
To guarantee the highest discovery rate, we search across 20+ contact search tools.
To maximize delivery rate and reduce bounce rate, we validate emails.
You can enrich your investor list with Shizune. Download it too.
What is Shizune?
Shizune is a 48,091 investor database updated daily.
With Shizune you can:
- browse the database
- use smart matching
- enrich with emails
- download
All you need to find investors for your startup.
Who is Shizune for?
Shizune is built for startup founders by startup founders.
If you are looking for funding for your startup, try the Shizune database — we have investors for every stage, industry, and country.
Is Shizune free?
Shizune is free forever. You can search and browse investors for free.
Email search and export are paid features.
For full info, visit our pricing.
Who built Shizune?
Shizune is built by founders with the goal of helping all founders raise funding no matter where they are.
Contact 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!